JULIE LESNESKI: Open Payments
NPI 1528470846 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,649 in 95 payments from 24 companies in 2025. Trend: 2023 $1,488 · 2024 $1,688 · 2025 $1,649
Food & beverage: $1,649
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $334 |
| Novo Nordisk Inc | 14 | $251 |
| PFIZER INC. | 11 | $196 |
| Lilly USA, LLC | 7 | $118 |
| Verona Pharma, Inc. | 5 | $95 |
| Dexcom, Inc. | 5 | $93 |
| GlaxoSmithKline, LLC. | 5 | $85 |
| Amgen Inc. | 3 | $53 |
| Stryker Corporation | 2 | $45 |
| Exact Sciences Corporation | 3 | $45 |
Products named: Wegovy, UBRELVY, Ohtuvayre, Dexcom G6 Transmitter, QULIPTA, NURTEC ODT, MOUNJARO, RINVOQ.
Industry payments across PA — which companies pay providers there.
